Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphangioleiomyomatosis.

Angelo M Taveira-DaSilva1, Wendy K Steagall, Joel Moss

  • 1Pulmonary-Critical Care Medicine Branch, NHLBI, NIH, Bethesda, MD 20892, USA. dasilvaa@nhlbi.nih.gov

Cancer Control : Journal of the Moffitt Cancer Center
|November 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High prevalence of TSC2 mutations in lung tissue samples from patients with sporadic lymphangioleiomyomatosis.

The European respiratory journal·2026
Same author

High-Throughput Proteomics in Lymphangioleiomyomatosis: Premelanosome Protein as a Diagnostic Biomarker, Construction of a Diagnosis Score, and Evidence of Neutrophil Involvement.

Chest·2026
Same author

Coil Sketching for Fast and Efficient 4D Lung MRI Reconstruction.

Magnetic resonance in medicine·2025
Same author

Publisher Correction: TRIM23 mediates cGAS-induced autophagy in anti-HSV defense.

Nature communications·2025
Same author

TRIM23 mediates cGAS-induced autophagy in anti-HSV defense.

Nature communications·2025
Same author

Atorvastatin in Severity-Stratified Pulmonary Sarcoidosis: A Phase II Randomized Controlled Trial.

American journal of respiratory and critical care medicine·2024
Same journal

Clinical Diagnosis Codes Identify Patients Unlikely to Receive Orders for Fecal Immunochemical Tests.

Cancer control : journal of the Moffitt Cancer Center·2026
Same journal

Passing the Baton: Succession Planning and Mentorship for Cancer Control in Low- and Middle-Income Countries.

Cancer control : journal of the Moffitt Cancer Center·2026
Same journal

Clinical Prediction Models to Guide the Selection of Patients for Colon Capsule Endoscopy Versus Colonoscopy Following FIT-Positive Screening.

Cancer control : journal of the Moffitt Cancer Center·2026
Same journal

Exercise During Chemotherapy Treatment as an Adjuvant Programme in Patients With Lymphoma (EDONOLA): Study Protocol for a Randomised Controlled Trial.

Cancer control : journal of the Moffitt Cancer Center·2026
Same journal

Effects of Home-Based Exercise With Telehealth Guidance in Lymphoma Survivors Entering Cardio-Oncology Rehabilitation: A Randomized Controlled Trial.

Cancer control : journal of the Moffitt Cancer Center·2026
Same journal

The Association Between Human Papillomavirus Type 16 E6 Seroprevalence and Degrees of Anal Disease Among Men With HIV: A Nested Case Control Study.

Cancer control : journal of the Moffitt Cancer Center·2026
See all related articles

Lymphangioleiomyomatosis (LAM) is a rare lung disease causing cysts and tumors. Current treatments are ineffective, but new therapeutic strategies are being developed.

Area of Science:

  • Pulmonary Medicine
  • Rare Diseases
  • Oncology

Background:

  • Lymphangioleiomyomatosis (LAM) is a rare neoplastic proliferation of smooth muscle-like cells.
  • LAM affects primarily women, leading to lung cysts, lymphatic abnormalities, and abdominal tumors.

Purpose of the Study:

  • To review the prevalence, pathology, clinical features, diagnosis, and treatment of LAM.
  • To highlight current understanding and future directions for LAM management.

Main Methods:

  • Review of large case series, registries, and clinical protocols.
  • Analysis of clinical presentation, imaging (CT scans), pulmonary function tests (FEV1, DLCO), and exercise testing.

Main Results:

  • LAM presents with progressive dyspnea, pneumothorax, chylothorax, or abdominal hemorrhage.

Related Experiment Videos

  • CT scans reveal lung cysts and abdominal tumors (angiomyolipomas, lymphangioleiomyomas).
  • Pulmonary and exercise tests show impaired gas exchange and ventilation.

    • Conclusions:

    • No definitive treatment currently exists for LAM.
    • Advances in cell biology offer potential for novel therapeutic strategies targeting angiogenesis and lymphangiogenesis.